CN111718387A - A Modular DNA Synthesis Method - Google Patents

A Modular DNA Synthesis Method Download PDF

Info

Publication number
CN111718387A
CN111718387A CN201910222602.4A CN201910222602A CN111718387A CN 111718387 A CN111718387 A CN 111718387A CN 201910222602 A CN201910222602 A CN 201910222602A CN 111718387 A CN111718387 A CN 111718387A
Authority
CN
China
Prior art keywords
nucleoside
group
modular
dna according
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910222602.4A
Other languages
Chinese (zh)
Inventor
王升启
何小羊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Pharmacology and Toxicology of AMMS
Original Assignee
Institute of Pharmacology and Toxicology of AMMS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Pharmacology and Toxicology of AMMS filed Critical Institute of Pharmacology and Toxicology of AMMS
Priority to CN201910222602.4A priority Critical patent/CN111718387A/en
Publication of CN111718387A publication Critical patent/CN111718387A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Saccharide Compounds (AREA)

Abstract

本发明提供了一种模块化DNA的合成方法,包括如下步骤:采用固相合成法以包含核苷模块单元的原料合成DNA;其中所述核苷模块单元通过两个以上的脱氧核苷酸偶联得到。本发明的合成方法提高了DNA长链合成的效率及保真度,具有一定的广谱适用性,值得广泛推广应用。

Figure 201910222602

The present invention provides a method for synthesizing modular DNA, comprising the following steps: adopting a solid-phase synthesis method to synthesize DNA from raw materials comprising nucleoside modular units; wherein the nucleoside modular units are coupled by two or more deoxynucleotides. Link to get. The synthesis method of the invention improves the efficiency and fidelity of DNA long-chain synthesis, has certain broad-spectrum applicability, and is worthy of wide popularization and application.

Figure 201910222602

Description

一种模块化DNA的合成方法A Modular DNA Synthesis Method

技术领域technical field

本发明涉及DNA合成领域,具体而言,涉及一种模块化的DNA合成方法。The invention relates to the field of DNA synthesis, in particular to a modular DNA synthesis method.

背景技术Background technique

近年来,随着合成生物学的发展,对DNA合成的保真度要求越来越高,传统的单一核苷逐步合成方法已难以满足需要,如何提高合成DNA的效率以及准确度是当今领域主要的研发方向。In recent years, with the development of synthetic biology, the requirements for the fidelity of DNA synthesis are getting higher and higher. The traditional single nucleoside step-by-step synthesis method has been unable to meet the needs. How to improve the efficiency and accuracy of DNA synthesis is the main field in today's field development direction.

传统上,DNA的合成以单个核苷为单一单体,采用脱保护-偶联-盖帽-氧化的‘四步法’循环模式进行合成,因以单一单体为基础,在合成长链时,每个循环中都需要进行酸脱保护,故在合成长链时,会经历大量酸脱保护的过程。但是,在酸性条件下,核苷上的嘌呤碱基不稳定,易脱落,从而导致合成的长链DNA会有大量碱基丢失,降低所得到的DNA长链的准确度,合成所需量的DNA长链成本升高。Traditionally, DNA synthesis takes a single nucleoside as a single monomer, and adopts a 'four-step method' cycle mode of deprotection-coupling-capping-oxidation. Because it is based on a single monomer, when synthesizing long chains, Acid deprotection is required in each cycle, so a large number of acid deprotection processes will be experienced when synthesizing long chains. However, under acidic conditions, the purine bases on the nucleosides are unstable and fall off easily, resulting in the loss of a large number of bases in the synthesized long-chain DNA, reducing the accuracy of the long-chain DNA obtained, and the synthesis of the required amount of DNA. The cost of long DNA chains increases.

同时,由于脱保护、偶联、盖帽等过程中不能完全定量反应,也会导致产生单核苷缺失((n-1)mer)的副产物,该产物难以分离纯化,严重影响DNA的保真度。At the same time, due to the incomplete quantitative reaction in the process of deprotection, coupling, capping, etc., the by-product of single nucleoside deletion ((n-1)mer) will also be produced, which is difficult to separate and purify, which seriously affects the fidelity of DNA. Spend.

此外,在合成常规的长链DNA时,A、G等偶联效率相对较低,也会影响所合成的长链DNA的合成效率以及准确度。尽量减少核苷单体在合成DNA长链时的偶联次数,能够提高所合成长链DNA的合成效率以及准确度,以合成100ntDNA为例,使用二聚体模块合成仅需50个循环即可完成,可减少50次以上的脱保护、偶联和盖帽过程,时间缩短一半,同时也避免难以纯化的(n-1)mer的副产物,因此,可提高DNA合成的效率和保真度。。In addition, when synthesizing conventional long-chain DNA, the coupling efficiency of A, G, etc. is relatively low, which also affects the synthesis efficiency and accuracy of the synthesized long-chain DNA. Minimizing the number of coupling times of nucleoside monomers in the synthesis of long DNA chains can improve the synthesis efficiency and accuracy of the synthesized long-chain DNA. Taking the synthesis of 100nt DNA as an example, it only takes 50 cycles to synthesize the dimer module. Completed, it can reduce more than 50 deprotection, coupling and capping processes, cut the time in half, and also avoid the by-products of (n-1)mers that are difficult to purify, therefore, the efficiency and fidelity of DNA synthesis can be improved. .

有鉴于此,特提出本发明。In view of this, the present invention is proposed.

发明内容SUMMARY OF THE INVENTION

本发明的目的在于提供一种采用模块化的脱氧核苷酸进行合成DNA的方法,本发明的合成方法充分提高了长片段寡核苷酸合成的速率,减少酸脱保护次数以降低脱嘌呤等合成副反应,避免A、G偶联效率低而降低合成效率的问题,具有非常广泛的适用度。The purpose of the present invention is to provide a method for synthesizing DNA using modular deoxynucleotides. The synthesis method of the present invention fully improves the synthesis rate of long-fragment oligonucleotides, reduces the number of acid deprotection times to reduce depurination, etc. Synthetic side reactions, avoiding the problem of low A and G coupling efficiency and reducing the synthesis efficiency, have a very wide range of applicability.

为了实现本发明的上述目的,特采用以下技术方案:In order to realize the above-mentioned purpose of the present invention, the following technical solutions are specially adopted:

本发明提供了一种DNA的合成方法,包括如下步骤:The invention provides a kind of synthetic method of DNA, comprising the steps:

采用固相合成法以包含核苷模块单元的原料合成DNA;Use solid-phase synthesis to synthesize DNA from raw materials containing nucleoside modular units;

其中所述核苷模块单元通过两个以上的脱氧核苷酸偶联得到;wherein the nucleoside modular unit is obtained by coupling two or more deoxynucleotides;

优选地,所述原料中还包括脱氧核苷酸单体。Preferably, the raw material also includes deoxynucleotide monomers.

上述合成方法中,通过采用核苷模块单元为原料来合成DNA,显著提高了合成效率,实现长片段寡核苷酸的高保真合成,并在此基础上减少合成原料及试剂的消耗,综合性地降低DNA合成成本,同时提高DNA合成的准确度。In the above synthesis method, by using nucleoside modular units as raw materials to synthesize DNA, the synthesis efficiency is significantly improved, the high-fidelity synthesis of long-segment oligonucleotides is realized, and the consumption of synthetic raw materials and reagents is reduced on this basis. It can reduce the cost of DNA synthesis and improve the accuracy of DNA synthesis at the same time.

优选地,作为进一步可实施的方案,进行偶联的核苷模块单元中的碱基为不同的碱基或相同的碱基。Preferably, as a further implementable solution, the bases in the nucleoside modular units for coupling are different bases or the same base.

优选地,作为进一步可实施的方案,所述核苷模块单元为二聚体模块单元、三聚体模块单元以及四聚体模块单元中的至少一种。Preferably, as a further implementable solution, the nucleoside modular unit is at least one of a dimer modular unit, a trimer modular unit and a tetrameric modular unit.

优选地,作为进一步可实施的方案,所述核苷模块单元为二聚体模块单元。Preferably, as a further implementable solution, the nucleoside modular unit is a dimer modular unit.

优选地,作为进一步可实施的方案,固相合成在DNA合成仪上进行。Preferably, as a further possible embodiment, the solid phase synthesis is carried out on a DNA synthesizer.

优选地,作为进一步可实施的方案,所述核苷模块单元的合成方法包括:Preferably, as a further implementable solution, the method for synthesizing the nucleoside modular unit includes:

(1)将保护基团保护的脱氧核苷与乙酰丙酸反应,碱性环境和催化条件下,获得活性基团被保护的脱氧核苷;(1) reacting the deoxynucleoside protected by the protective group with levulinic acid, under alkaline environment and catalytic conditions, to obtain the deoxynucleoside protected by the active group;

(2)脱去其5’-羟基的保护基团,与亚磷酰胺核苷催化偶联,氧化;(2) Remove the protective group of its 5'-hydroxyl group, catalyze coupling with phosphoramidite nucleoside, and oxidize;

(3)脱去其3’-羟基的保护基团,连接亚磷酰胺;(3) remove the protecting group of its 3'-hydroxyl, connect phosphoramidite;

(4)当所述核苷模块单元中的碱基为两个以上时,重复上述步骤(2)-(3)以得到所述核苷模块单元;(4) when there are two or more bases in the nucleoside modular unit, repeat the above steps (2)-(3) to obtain the nucleoside modular unit;

优选地,所述保护基团选自三苯甲基基团、单甲氧基三苯甲基基团、二甲氧基三苯甲基基团中的其中一种。Preferably, the protecting group is selected from one of a trityl group, a monomethoxytrityl group, and a dimethoxytrityl group.

优选地,作为进一步可实施的方案,催化偶联的催化剂为1H-四唑、5-苄硫基四唑、4,5-二氰基咪唑中的其中一种。Preferably, as a further implementable solution, the catalyst for catalyzing the coupling is one of 1H-tetrazole, 5-benzylthiotetrazole, and 4,5-dicyanoimidazole.

优选地,作为进一步可实施的方案,催化偶联的催化剂为4,5-二氰基咪唑。Preferably, as a further implementable solution, the catalyst for catalyzing the coupling is 4,5-dicyanoimidazole.

优选地,作为进一步可实施的方案,与质子酸反应以脱去其5’-羟基的保护基团。Preferably, as a further implementable scheme, reaction with a protonic acid is used to remove the protecting group of its 5'-hydroxyl group.

优选地,所述质子酸选自三氯乙酸、二氯乙酸中的其中一种。Preferably, the protic acid is selected from one of trichloroacetic acid and dichloroacetic acid.

优选地,作为进一步可实施的方案,水合肼催化以脱去其3’-羟基的保护基团。Preferably, as a further implementable solution, hydrazine hydrate is catalyzed to remove the protecting group of its 3'-hydroxyl group.

与现有技术相比,本发明的有益效果为:Compared with the prior art, the beneficial effects of the present invention are:

1)本发明通过采用模块化脱氧核苷酸为原料来进行长链寡核苷酸的合成,从而能够减少在寡核苷酸链合成时进行的酸脱保护的次数,可以有效地防止在酸性条件下脱氧核苷酸的碱基不稳定,易脱落的问题,并可以减少合成步骤,从而提高寡核苷酸链的合成效率,准确度;1) The present invention uses modular deoxynucleotides as raw materials to synthesize long-chain oligonucleotides, thereby reducing the number of acid deprotection performed during the synthesis of oligonucleotide chains, and effectively preventing acid deprotection. The base of deoxynucleotide is unstable and easy to fall off under the conditions, and the synthesis steps can be reduced, thereby improving the synthesis efficiency and accuracy of the oligonucleotide chain;

2)本发明的合成方法改变了原本单一单体的循环模式,将合成模式变成模块化的循环模式,或者模块化+单体的循环模式,这样一来避免了A、G偶联效率低而降低合成效率的问题,具有非常广泛的适用度。2) The synthesis method of the present invention changes the original cycle mode of a single monomer, and changes the synthesis mode into a modular cycle mode, or a modular + monomer cycle mode, thus avoiding the low coupling efficiency of A and G. The problem of reducing synthesis efficiency has a very wide range of applicability.

附图说明Description of drawings

为了更清楚地说明本发明实施例或现有技术中的技术方案,以下将对实施例或现有技术描述中所需要使用的附图作简单地介绍。In order to illustrate the embodiments of the present invention or the technical solutions in the prior art more clearly, the following briefly introduces the accompanying drawings that are required to be used in the description of the embodiments or the prior art.

图1为本发明实施例1中TC dimer的合成路线示意图;Fig. 1 is the synthetic route synoptic diagram of TC dimer in the embodiment of the present invention 1;

图2为本发明实施例1的二聚体TC dimer的质谱图;Fig. 2 is the mass spectrogram of the dimer TC dimer of the embodiment of the present invention 1;

图3为采用本发明实施例1的二聚体TC dimer合成目标引物E120R-44的HPLC图;Fig. 3 is the HPLC figure that adopts the dimer TC dimer of the embodiment of the present invention 1 to synthesize target primer E120R-44;

图4为本发明实施例2中采用脱氧核苷单体合成引物E120R-44的HPLC图;Fig. 4 is the HPLC chart of adopting deoxynucleoside monomer to synthesize primer E120R-44 in the embodiment of the present invention 2;

图5为采用本发明实施例1的二聚体TC dimer合成目标引物P5430-22的HPLC图;Fig. 5 is the HPLC figure that adopts the dimer TC dimer of the embodiment of the present invention 1 to synthesize target primer P5430-22;

图6为本发明实施例2中采用脱氧核苷单体合成引物P5430-22的HPLC图;Fig. 6 is the HPLC chart of adopting deoxynucleoside monomer to synthesize primer P5430-22 in the embodiment of the present invention 2;

图7为本发明核苷模块单元的结构示意图;Fig. 7 is the structural representation of the nucleoside modular unit of the present invention;

图8为本发明模块化DNA的合成示意图。Figure 8 is a schematic diagram of the synthesis of the modular DNA of the present invention.

具体实施方式Detailed ways

下面将结合实施例对本发明的实施方案进行详细描述,但是本领域技术人员将会理解,下列实施例仅用于说明本发明,而不应视为限制本发明的范围。实施例中未注明具体条件者,按照常规条件或制造商建议的条件进行。所用试剂或仪器未注明生产厂商者,均为可以通过市售购买获得的常规产品。The embodiments of the present invention will be described in detail below with reference to the examples, but those skilled in the art will understand that the following examples are only used to illustrate the present invention and should not be regarded as limiting the scope of the present invention. If the specific conditions are not indicated in the examples, it is carried out according to the conventional conditions or the conditions suggested by the manufacturer. The reagents or instruments used without the manufacturer's indication are conventional products that can be purchased from the market.

本发明提供了一种DNA的合成方法,包括如下步骤:The invention provides a kind of synthetic method of DNA, comprising the steps:

采用固相合成法以包含核苷模块单元的原料合成DNA;Use solid-phase synthesis to synthesize DNA from raw materials containing nucleoside modular units;

其中所述核苷模块单元通过两个以上的脱氧核苷酸偶联得到。The nucleoside modular unit is obtained by coupling two or more deoxynucleotides.

优选地,所述原料中还包括脱氧核苷酸单体。Preferably, the raw material also includes deoxynucleotide monomers.

上述合成方法中,通过采用核苷模块单元为原料来合成DNA,显著提高了合成效率,实现长片段寡核苷酸的高保真合成,并在此基础上减少合成原料及试剂的消耗,综合性地降低DNA合成成本,同时提高DNA合成的准确度。In the above synthesis method, by using nucleoside modular units as raw materials to synthesize DNA, the synthesis efficiency is significantly improved, the high-fidelity synthesis of long-segment oligonucleotides is realized, and the consumption of synthetic raw materials and reagents is reduced on this basis. It can reduce the cost of DNA synthesis and improve the accuracy of DNA synthesis at the same time.

原料可直接选择模块化的核苷模块单元,或选择模块化与脱氧核苷酸单体结合的方式,可根据实际情况进行灵活选择。The raw material can be directly selected from the modular nucleoside module unit, or the combination of modular and deoxynucleotide monomers can be selected, which can be flexibly selected according to the actual situation.

优选地,作为进一步可实施的方案,进行偶联的核苷模块单元中的碱基为不同的碱基或相同的碱基,所以核苷模块单元本身所包含的脱氧核苷酸类型也是多种多样的,A、G、C、T可以进行任意组合形成核苷模块单元。Preferably, as a further feasible solution, the bases in the nucleoside modular unit to be coupled are different bases or the same base, so the nucleoside modular unit itself contains various types of deoxynucleotides. Variously, A, G, C, T can be combined arbitrarily to form a nucleoside modular unit.

优选地,作为进一步可实施的方案,所述核苷模块单元为二聚体偶联单元、三聚体偶联单元以及四聚体偶联单元中的至少一种。Preferably, as a further implementable solution, the nucleoside modular unit is at least one of a dimer coupling unit, a trimer coupling unit and a tetramer coupling unit.

优选地,作为进一步可实施的方案,所述核苷模块单元为二聚体偶联单元,二聚体偶联单元可以为AA、AG、AC、AT、GG、CT、TT等16种组合方式。Preferably, as a further feasible solution, the nucleoside modular unit is a dimer coupling unit, and the dimer coupling unit can be 16 combinations of AA, AG, AC, AT, GG, CT, TT, etc. .

那么,三聚体偶联单元其所包含的组合情况更多,不一一进行列举。核苷模块单元的具体结构参见图7,模块化DNA的合成路线参见图8。Then, there are more combinations of the trimer coupling unit, which are not listed one by one. The specific structure of the nucleoside modular unit is shown in Figure 7, and the synthetic route of the modular DNA is shown in Figure 8.

优选地,作为进一步可实施的方案,所述固相合成法在DNA合成仪上进行。Preferably, as a further implementable solution, the solid-phase synthesis method is performed on a DNA synthesizer.

更优选地,以DNA合成仪为设备,以4,5-二氰基咪唑为催化剂,合成出长链寡核苷酸。More preferably, the long-chain oligonucleotide is synthesized by using a DNA synthesizer as a device and 4,5-dicyanoimidazole as a catalyst.

优选地,作为进一步可实施的方案,所述核苷模块单元的合成方法包括:Preferably, as a further implementable solution, the method for synthesizing the nucleoside modular unit includes:

(1)将保护基团保护的脱氧核苷与乙酰丙酸反应,碱性环境和催化条件下,获得活性基团被保护的脱氧核苷;(1) reacting the deoxynucleoside protected by the protective group with levulinic acid, under alkaline environment and catalytic conditions, to obtain the deoxynucleoside protected by the active group;

(2)脱去其5’-羟基的保护基团,与亚磷酰胺核苷催化偶联,氧化;(2) Remove the protective group of its 5'-hydroxyl group, catalyze coupling with phosphoramidite nucleoside, and oxidize;

(3)脱去其3’-羟基的保护基团,连接亚磷酰胺;(3) remove the protecting group of its 3'-hydroxyl, connect phosphoramidite;

(4)当所述核苷模块单元中的碱基为两个以上时,重复上述步骤(2)-(3)以得到所述核苷模块单元。(4) When there are two or more bases in the nucleoside modular unit, repeat the above steps (2)-(3) to obtain the nucleoside modular unit.

优选地,所述保护基团选自三苯甲基基团、单甲氧基三苯甲基基团、二甲氧基三苯甲基基团中的其中一种。Preferably, the protecting group is selected from one of a trityl group, a monomethoxytrityl group, and a dimethoxytrityl group.

优选地,作为进一步可实施的方案,催化偶联的催化剂为1H-四唑、5-苄硫基四唑、4,5-二氰基咪唑中的其中一种。Preferably, as a further implementable solution, the catalyst for catalyzing the coupling is one of 1H-tetrazole, 5-benzylthiotetrazole, and 4,5-dicyanoimidazole.

优选地,作为进一步可实施的方案,催化偶联的催化剂为4,5-二氰基咪唑。Preferably, as a further implementable solution, the catalyst for catalyzing the coupling is 4,5-dicyanoimidazole.

优选地,作为进一步可实施的方案,与质子酸反应以脱去其5’-羟基的保护基团。Preferably, as a further implementable scheme, reaction with a protonic acid is used to remove the protecting group of its 5'-hydroxyl group.

优选地,所述质子酸选自三氯乙酸、二氯乙酸中的其中一种。Preferably, the protic acid is selected from one of trichloroacetic acid and dichloroacetic acid.

优选地,作为进一步可实施的方案,水合肼催化以脱去其3’-羟基的保护基团。Preferably, as a further implementable solution, hydrazine hydrate is catalyzed to remove the protecting group of its 3'-hydroxyl group.

具体地,以二聚体为例,具体偶联方法包括如下步骤:Specifically, taking the dimer as an example, the specific coupling method includes the following steps:

(1)DMT保护的脱氧核苷与乙酰丙酸(levulinic acid)反应,生成3’-Lev,5’-DMTr保护的脱氧核苷,上述反应需在EDCI作为碱,DMAP做催化剂,DCM作溶剂,室温条件下进行。(1) The DMT-protected deoxynucleoside reacts with levulinic acid to generate 3'-Lev, 5'-DMTr-protected deoxynucleoside. The above reaction requires EDCI as a base, DMAP as a catalyst, and DCM as a solvent , at room temperature.

(2)将(1)所获得的产物溶于二氯乙酸进行脱5’位DMTr保护,得到3’-Lev保护的脱氧核苷。(2) dissolving the product obtained in (1) in dichloroacetic acid to deprotect the 5'-position DMTr to obtain a 3'-Lev-protected deoxynucleoside.

(3)将(2)所获得的产物溶于无水二氯甲烷中,在1H-四唑的催化下于与亚磷酰胺核苷反应,得到二聚产物。(3) Dissolving the product obtained in (2) in anhydrous dichloromethane, and reacting with phosphoramidite nucleoside under the catalysis of 1H-tetrazole to obtain a dimerized product.

(4)将(3)所得的产物用碘氧化剂进行氧化,得到氧化后的二聚产物。(4) The product obtained in (3) is oxidized with an iodine oxidant to obtain an oxidized dimerized product.

(5)将(4)所得的产物用水合肼催化脱去3’位Lev的保护。(5) The product obtained in (4) is catalyzed by hydrazine hydrate to remove the protection of the 3'-position Lev.

(6)将(5)所得的产物与2-氰乙基-双(N,N-二异丙基)亚磷酰胺反应在3’位引入亚磷酰胺。(6) The product obtained in (5) is reacted with 2-cyanoethyl-bis(N,N-diisopropyl)phosphoramidite to introduce a phosphoramidite at the 3' position.

上述各个步骤中,首先将3’位的羟基用乙酰丙酸保护后,再脱去5’位羟基保护的DMTr,目的是为了让其与亚磷酰胺核苷反应时,只以一种产物为主要产物,能够有效减少,甚至避免副产物的出现,更有助于反应完后的分离纯化。In the above-mentioned steps, after first protecting the hydroxy group at the 3' position with levulinic acid, then remove the DMTr protected by the hydroxyl group at the 5' position, in order to allow it to react with the phosphoramidite nucleoside, only take a product as The main product can effectively reduce or even avoid the appearance of by-products, which is more conducive to the separation and purification after the reaction.

由于脱氧核苷有两个裸露的羟基,分别位于3’碳和5’碳上。如果不进行3’碳上羟基的保护,则不同脱氧核苷上的这两个位置的羟基可以进行反应,从而产生其他的二聚体,影响反应产率。同时,3’位保护的乙酰丙基不会被所用的碘氧化剂所氧化,并且在反应后,容易脱保护,因此被选作保护基来保护3’位羟基。Since deoxynucleosides have two exposed hydroxyl groups, which are located on the 3' carbon and the 5' carbon, respectively. If the hydroxyl group on the 3' carbon is not protected, the hydroxyl groups at these two positions on different deoxynucleosides can react, resulting in other dimers and affecting the reaction yield. At the same time, the 3'-protected acetylpropyl group will not be oxidized by the iodine oxidant used, and after the reaction, it is easily deprotected, so it is selected as a protecting group to protect the 3'-hydroxyl group.

在步骤(2)中,将原料溶于二氯甲烷后,加入5倍量的二氯乙酸,在室温下进行脱DMTr的反应,当溶液的颜色变为酒红色,且不再变浅时,进行TLC检验,反应物完全反应后,立刻加入饱和碳酸氢钠水溶液终止反应,以防止脱氧核苷长时间处于强酸性条件下碱基脱落的情况发生。In step (2), after the raw material is dissolved in dichloromethane, 5 times of dichloroacetic acid is added, and the reaction of removing DMTr is carried out at room temperature, when the color of the solution becomes wine red and no longer becomes lighter, Carry out TLC test. After the reactants are completely reacted, saturated aqueous sodium bicarbonate solution is added immediately to stop the reaction to prevent the deoxynucleosides from being exposed to strong acid conditions for a long time.

在步骤(3)中,将1H-四唑与亚磷酰胺脱氧胸腺核苷(dT)溶于无水二氯甲烷后,再将3’-Lev保护脱氧胞苷(dC)加入,反应后可得到相应的二聚体模块产物。使用无水二氯甲烷作溶剂,可以更好的保证反应体系无水,防止亚磷酰胺在有水存在的情况下发生分解。除1H-四唑外,本实验中还使用过5-苄硫基四唑和4,5-二氰基咪唑(DCI)。当以5-苄硫基四唑为催化剂时,对反应没有太大影响,只是在萃取,及后处理时容易造成严重的乳化现象。当以DCI为催化剂时,因为DCI在在紫外灯下显色,因此,TLC时需要DCI的对照。但因为DCI可以与碳酸氢钠水溶液发生反应,故在反应后处理中,可以被碳酸氢钠水溶液洗掉,而不影响产品纯度。In step (3), after dissolving 1H-tetrazole and phosphoramidite deoxythymidine (dT) in anhydrous dichloromethane, then adding 3'-Lev protected deoxycytidine (dC), after the reaction, the The corresponding dimer modular product was obtained. Using anhydrous dichloromethane as the solvent can better ensure that the reaction system is anhydrous and prevent the phosphoramidite from decomposing in the presence of water. In addition to 1H-tetrazole, 5-benzylthiotetrazole and 4,5-dicyanoimidazole (DCI) were also used in this experiment. When 5-benzylthiotetrazole is used as the catalyst, it has no great influence on the reaction, but it is easy to cause serious emulsification during extraction and post-processing. When DCI is used as the catalyst, since DCI develops color under UV light, a DCI control is required for TLC. But because DCI can react with sodium bicarbonate aqueous solution, it can be washed off by sodium bicarbonate aqueous solution in the post-reaction treatment without affecting the product purity.

在步骤(4)中,把氧化剂加入到原料中,经过搅拌即可得到氧化后产物。由于氧化剂具有较深的颜色,随反应进行,碘逐渐减少,溶液颜色会逐渐变浅,当颜色不再变浅后,说明反应完成,所有亚磷酰胺都被氧化,再用饱和硫代硫酸钠水溶液终止反应后,处理反应液可得到所需产物。In step (4), the oxidizing agent is added to the raw material, and the oxidized product can be obtained after stirring. Since the oxidant has a darker color, as the reaction proceeds, the iodine gradually decreases, and the color of the solution will gradually become lighter. When the color no longer becomes lighter, it indicates that the reaction is complete and all phosphoramidites have been oxidized. After the aqueous solution terminates the reaction, the desired product can be obtained by processing the reaction solution.

在步骤(5)中,以水合肼作为催化剂,将其溶解在新配置的溶液中(吡啶:冰醋酸=3:2)中,待其完全溶解后再加入反应瓶中,加入到反应液中搅拌。TLC检测反应完成后,将反应瓶放入冰浴中,加入丙酮搅拌破坏肼以终止反应。In step (5), using hydrazine hydrate as a catalyst, it is dissolved in a newly configured solution (pyridine: glacial acetic acid = 3:2), and after it is completely dissolved, it is added to the reaction flask and added to the reaction solution Stir. After the completion of the reaction detected by TLC, the reaction flask was placed in an ice bath, and acetone was added to stir to destroy the hydrazine to terminate the reaction.

在步骤(6)中,由于亚磷酰胺的不稳定性,该反应必须使用无水试剂,同时,在反应结束后,产品需在氮气保护下,放入冰箱中冷冻储存。In step (6), due to the instability of phosphoramidite, the reaction must use anhydrous reagents, and at the same time, after the reaction is completed, the product needs to be placed in a refrigerator for freezing storage under nitrogen protection.

由于各个步骤的产物极性较大,在进行合成时,均采用二氯甲烷与甲醇混合液的TLC展开剂,同时,在使用色谱柱时,洗脱剂采用0-10%甲醇-二氯甲烷混合液体系。Due to the high polarity of the products in each step, during the synthesis, the TLC developing solvent of a mixture of dichloromethane and methanol was used. At the same time, when using a chromatographic column, the eluent was 0-10% methanol-dichloromethane. mixed liquid system.

此外,各步反应均在室温下搅拌进行。除步骤(3)亚磷酰胺氧化,步骤(5)3’位脱Lev保护外,均采取常规处理,即萃取后,依次使用饱和碳酸氢钠水溶液,水,饱和氯化钠水溶液洗涤后,用无水硫酸镁干燥,浓缩。In addition, each step of the reaction was carried out with stirring at room temperature. Except for step (3) phosphoramidite oxidation and step (5) de-Lev protection at 3' position, conventional treatment is adopted, that is, after extraction, saturated aqueous sodium bicarbonate solution, water, and saturated aqueous sodium chloride solution are used in order to wash, then use Dry over anhydrous magnesium sulfate and concentrate.

步骤(3)在萃取后,需要先使用饱和硫代硫酸钠洗涤洗去残存的碘后在进行常规洗涤。步骤(5)先在40℃下减压蒸馏以除去萃取剂二氯甲烷,再向剩余溶液中加入甲苯搅拌均匀后,在50℃下减压蒸馏以除去吡啶。In step (3), after the extraction, it is necessary to first use saturated sodium thiosulfate to wash away the residual iodine, and then carry out conventional washing. In step (5), distill under reduced pressure at 40° C. to remove the extractant dichloromethane, then add toluene to the remaining solution and stir evenly, and then distill under reduced pressure at 50° C. to remove pyridine.

在步骤(3)中,反应后会有部分脱氧胞苷(dC)存在,其与TC二聚体的极性相近,在TLC中位置非常接近,无法用色谱柱方法分离。但脱氧胞苷的存在对后续的氧化以及3’脱Lev不会造成影响。因此,可以在步骤(5)脱3’位保护后在进行色谱柱分离纯化,而(3)、(4)步完成后不需要使用色谱柱分离纯化。In step (3), there will be part of deoxycytidine (dC) after the reaction, which has similar polarity to TC dimer, and its position is very close in TLC, so it cannot be separated by chromatographic column method. However, the presence of deoxycytidine has no effect on subsequent oxidation and 3' deLev. Therefore, chromatographic column separation and purification can be performed after step (5) is deprotected at the 3' position, while chromatographic column separation and purification is not required after steps (3) and (4) are completed.

在本发明的各步反应中,都使用比较温和的反应条件,尽量避免造成碱基脱落或其他情况使得脱氧核苷发生分解的情况。In each step of the reaction of the present invention, relatively mild reaction conditions are used, and the deoxynucleosides are decomposed as far as possible due to the shedding of bases or other conditions.

下面通过具体的实施方式对本发明的方案进行阐述:The scheme of the present invention is described below by specific embodiments:

实施例1Example 1

1)把EDCI(4.5g,23.7mmol),DMAP(0.1g,7.9mmol),乙酰丙酸4(2.75g,23.7mmol)溶于二氯甲烷(20mL)后,加入原料1(5g,7.89mmol)并持续搅拌过夜。TLC检测DMTr-dC反应完全后,用萃取,并依次使用饱和碳酸氢钠水溶液,水,饱和食盐水洗涤,干燥,浓缩后得到产物粗品2(7.37g,产率124%)ESI-MS m/z[M+H]+=661.68;1) After dissolving EDCI (4.5 g, 23.7 mmol), DMAP (0.1 g, 7.9 mmol), levulinic acid 4 (2.75 g, 23.7 mmol) in dichloromethane (20 mL), add raw material 1 (5 g, 7.89 mmol) ) and continued stirring overnight. After TLC detected that the DMTr-dC reaction was complete, it was extracted with an aqueous saturated sodium bicarbonate solution, washed with water and saturated brine, dried, and concentrated to obtain a crude product 2 (7.37 g, yield 124%) ESI-MS m/ z[M+H] + =661.68;

2)把原料2(1.8g,2.37mmol)溶于无水二氯甲烷后,加入二氯乙酸(0.98mL,11.85mmol)。反应至TLC检测中没有原料剩余,加入饱和碳酸氢钠水溶液终止反应。用DCM萃取后洗涤干燥浓缩。过滤析出固体为部分产物(0.3889g),剩余滤液浓缩后使用闪柱纯化(洗脱剂:0-10%MeOH/DCM)得到第二部分产物(0.59g),集中可得产物3共计1.0g,产率96.4%。ESI-MS m/z[M+H]+=316.33;2) After dissolving raw material 2 (1.8 g, 2.37 mmol) in anhydrous dichloromethane, dichloroacetic acid (0.98 mL, 11.85 mmol) was added. The reaction was carried out until no starting material remained in the TLC detection, and saturated aqueous sodium bicarbonate solution was added to terminate the reaction. It was extracted with DCM, washed, dried and concentrated. The solid precipitated by filtration was part of the product (0.3889g), the remaining filtrate was concentrated and purified by flash column (eluent: 0-10% MeOH/DCM) to obtain the second part of the product (0.59g), a total of 1.0g of product 3 was obtained , the yield was 96.4%. ESI-MS m/z[M+H] + =316.33;

3)将原料3(6.35g,14.8mmol),与1H-四唑(1.04g,14.8mmol)溶于无水DCM(70mL)后,将5(亚磷酰胺dT)(10.5g,14.1mmol)加入反应瓶中,并搅拌过夜。反应至TLC中没有5存在时,加入饱和氢氧化钠溶液终止反应。用DCM萃取,洗涤,干燥后减压蒸馏,得到粗品6(16.82g,产率104%),ESI-MS m/z[M+H]+=1306.39;3) After dissolving raw material 3 (6.35 g, 14.8 mmol) and 1H-tetrazole (1.04 g, 14.8 mmol) in dry DCM (70 mL), 5 (phosphoramidite dT) (10.5 g, 14.1 mmol) was dissolved in anhydrous DCM (70 mL). Add to reaction flask and stir overnight. When no 5 was present in TLC, saturated sodium hydroxide solution was added to terminate the reaction. Extracted with DCM, washed, dried and distilled under reduced pressure to obtain crude product 6 (16.82 g, yield 104%), ESI-MS m/z [M+H] + =1306.39;

4)将原料6(以上一步为纯化产品粗品为原料,3.19g),加入反应瓶中,加入氧化剂(0.05M I2/pyridine,THF,H2O,71.3mL)持续搅拌至TLC中没有原料剩余,加入饱和硫代硫酸钠溶液终止反应,用DCM萃取后,依次用饱和硫代硫酸钠水溶液,水,饱和食盐水洗涤并干燥,浓缩后得到产物粗品7(3.235g,产率100%)ESI-MS m/z[M+H]+=1111.34;4) The raw material 6 (the crude product of the purified product in the above step is the raw material, 3.19 g) was added to the reaction flask, and an oxidant (0.05M I2/pyridine, THF, H 2 O, 71.3 mL) was added and stirred until no raw material remained in the TLC. , added saturated sodium thiosulfate solution to terminate the reaction, extracted with DCM, washed with saturated sodium thiosulfate aqueous solution, water, and saturated brine successively and dried, concentrated to obtain crude product 7 (3.235 g, yield 100%) ESI -MS m/z[M+H] + =1111.34;

5)将0.69mL水合肼溶于吡啶,冰醋酸的混合溶液(吡啶:冰醋酸=12mL:8mL)作为催化剂。把原料7(100mg,0.092mmol)溶于10mL吡啶中,向其中加入2mL催化剂,并在常温下搅拌15min,TLC检测没有原料后,将反应瓶放入冰浴中,加入2mL丙酮继续搅拌10min。用DCM稀释后,用DCM萃取,洗涤干燥。浓缩后,加入甲苯共沸除去吡啶。过柱(DCM/MeOH0~10%)得到产物8(40mg,产率44%)ESI-MS m/z[M+H]+=1013.31;5) 0.69 mL of hydrazine hydrate was dissolved in pyridine, and a mixed solution of glacial acetic acid (pyridine: glacial acetic acid = 12 mL: 8 mL) was used as a catalyst. Raw material 7 (100 mg, 0.092 mmol) was dissolved in 10 mL of pyridine, 2 mL of catalyst was added to it, and stirred at room temperature for 15 min. After TLC detected no raw material, the reaction flask was placed in an ice bath, and 2 mL of acetone was added to continue stirring for 10 min. After dilution with DCM, extraction with DCM, washing and drying. After concentration, toluene was added to remove pyridine azeotropically. Passing through column (DCM/MeOH 0~10%) gave product 8 (40 mg, yield 44%) ESI-MS m/z [M+H] + =1013.31;

6)取2-氰乙基-双(N,N-二异丙基基)亚磷酰胺(9.6g,31.64mmol),1H-四唑(0.5g,7.12mmol)溶于40mL无水DCM中。待溶液澄清后加入反应物8(7.71g,7.91mmol),并搅拌过夜。加入饱和碳酸氢钠水溶液终止反应,用DCM萃取后洗涤,干燥,浓缩。过柱(DCM/MeOH=0~10%)得到产物9(2.8g,产率30%)ESI-MS m/z[M+H]+=1213.41。6) Dissolve 2-cyanoethyl-bis(N,N-diisopropyl)phosphoramidite (9.6g, 31.64mmol) and 1H-tetrazole (0.5g, 7.12mmol) in 40mL of anhydrous DCM . After the solution was clear, reactant 8 (7.71 g, 7.91 mmol) was added and stirred overnight. The reaction was quenched by addition of saturated aqueous sodium bicarbonate solution, extracted with DCM, washed, dried and concentrated. Column passing (DCM/MeOH=0-10%) gave product 9 (2.8 g, yield 30%) ESI-MS m/z [M+H] + =1213.41.

结论:TC二聚体(TC-dimer)合成路线参见附图1,附图2为实施例1合成的目标化合物的质谱图。Conclusion: The synthetic route of TC dimer (TC-dimer) is shown in Figure 1, and Figure 2 is the mass spectrum of the target compound synthesized in Example 1.

从附图2的质谱图中可以看出,已经得到所需合成的TC dimer。说明了本实验方法能够成功的合成相应的目标化合物,通过与单一单体DNA链合成方法相对比,证实了模块+单一单体循环合成DNA长链的方法的可实施性。It can be seen from the mass spectrum of Fig. 2 that the desired synthetic TC dimer has been obtained. It is demonstrated that this experimental method can successfully synthesize the corresponding target compounds. By comparing with the single monomer DNA chain synthesis method, the feasibility of the method of modular + single monomer cycle synthesis of long DNA chains is confirmed.

实施例2Example 2

将上述实施例1合成的TC dimer用于实际DNA链的合成。The TC dimer synthesized in Example 1 above was used to synthesize the actual DNA strand.

共合成两组DNA链,分别为GAAGACCCGGACCCCTTGCTC和GCTAAGCTTAGTCTCTCATTACTAATGG。每组按照以TC dimer为原料和以DT和DC单体为原料对比进行。如下表1-2所示,使用机器为LK-48DNA合成仪器,运行程序为LK-48DNA合成仪器运行程序。Two sets of DNA strands were synthesized, namely GAAGACCCGGACCCCTTGCTC and GCTAAGCTTAGTCTCTCATTACTAATGG. Each group was compared with TC dimer as raw material and DT and DC monomers as raw materials. As shown in Table 1-2 below, the machine used is the LK-48 DNA synthesis instrument, and the operation program is the operation program of the LK-48 DNA synthesis instrument.

表1引物序列Table 1 Primer sequences

P5430-22P5430-22 GCTAAGCTTAGA“TC”“TC”“TC”ATTACTAATGGGCTAAGCTTAGA "TC" "TC" "TC" ATTACTAATGG E120R-44E120R-44 GAAGACCCGGACCCCTTGC“TC”GAAGACCCGGACCCCTTGC "TC"

表2每种试剂每步实际打液量:Table 2 The actual volume of each reagent in each step:

试剂reagent 打液量(μL)Liquid volume (μL) 催化剂catalyst 50.0050.00 “TC”"TC" 40.0040.00 dTdT 40.0040.00 dAdA 40.0040.00 dCdC 40.0040.00 dGdG 40.0040.00 CAP-BCAP-B 40.0040.00 CAP-ACAP-A 40.0040.00 OX-1OX-1 70.0070.00 ACNACN 160.00160.00

E120R-44引物分别采用TC dimer(“TC”)为原料和以dT和dC单体为原料对比的结论:图3为TC dimer合成出来的引物的HPLC图,图4为采用dT和dC单体合成出来的引物的HPLC图。The E120R-44 primers use TC dimer (“TC”) as raw material and dT and dC monomers as raw materials respectively. Comparison of the conclusions: Figure 3 is the HPLC chart of the primers synthesized by TC dimer, and Figure 4 is the use of dT and dC monomers. HPLC profile of the synthesized primers.

图3中,目标产物的保留时间为3.873min,峰面积4466332,峰面积占比91.06%,峰高544440,OD:6.56。In Figure 3, the retention time of the target product was 3.873 min, the peak area was 4466332, the peak area accounted for 91.06%, the peak height was 544440, and OD: 6.56.

图4中,目标产物的保留时间为3.879min,峰面积11407516,峰面积占比86.77%,峰高1376561,OD:16.8。In Figure 4, the retention time of the target product was 3.879 min, the peak area was 11407516, the peak area accounted for 86.77%, the peak height was 1376561, and OD: 16.8.

由图3-4可知,3’端为TC dime的引物合成出来纯度较好(因为只有连上TC dime的引物才能连接下一个单体)但OD值较低。It can be seen from Figure 3-4 that the primers with TC dime at the 3' end are synthesized with good purity (because only the primers connected to TC dime can connect to the next monomer) but the OD value is low.

P5430-22引物分别采用TC dimer为原料和以dT和dC单体为原料对比的结论:图5为TC dimer合成出来的引物的HPLC图,图6为采用dT和dC单体合成出来的引物的HPLC图。P5430-22 primers use TC dimer as raw materials and dT and dC monomers as raw materials respectively. Comparison of the conclusions: Figure 5 is the HPLC chart of the primers synthesized by TC dimer, and Figure 6 is the primers synthesized by using dT and dC monomers. HPLC chart.

图5中,目标产物的保留时间为4.313min,峰面积494923,峰面积占比7.30%,峰高55063,OD值0.6。In Figure 5, the retention time of the target product was 4.313 min, the peak area was 494923, the peak area accounted for 7.30%, the peak height was 55063, and the OD value was 0.6.

图6中,目标产物的保留时间为4.330min,峰面积8738890,峰面积占比86.75%,峰高1020156,OD值31。In Figure 6, the retention time of the target product was 4.330 min, the peak area was 8738890, the peak area accounted for 86.75%, the peak height was 1020156, and the OD value was 31.

在图5中,保留时间为4.313min的峰为目标产物,尽管相比于正常合成出的引物收率低,但峰形对称,保留时间相似的副产物含量低。In Figure 5, the peak with a retention time of 4.313 min is the target product. Although the yield is lower than that of the normally synthesized primers, the peak shape is symmetrical, and the content of by-products with similar retention times is low.

通过上述对比可以看出,所合成的脱氧核苷酸模块能够运用在DNA寡核苷酸链的合成上,并且具有一定的效果。It can be seen from the above comparison that the synthesized deoxynucleotide modules can be used in the synthesis of DNA oligonucleotide chains and have certain effects.

尽管已用具体实施例来说明和描述了本发明,然而应意识到,在不背离本发明的精神和范围的情况下可以作出许多其它的更改和修改。因此,这意味着在所附权利要求中包括属于本发明范围内的所有这些变化和修改。Although specific embodiments of the present invention have been illustrated and described, it should be understood that various other changes and modifications can be made without departing from the spirit and scope of the invention. Therefore, it is intended that all such changes and modifications as fall within the scope of this invention be included in the appended claims.

Claims (10)

1.一种模块化DNA的合成方法,其特征在于,包括如下步骤:1. a synthetic method of modular DNA, is characterized in that, comprises the steps: 采用固相合成法以包含核苷模块单元的原料合成DNA;Use solid-phase synthesis to synthesize DNA from raw materials containing nucleoside modular units; 其中所述核苷模块单元通过两个以上的脱氧核苷酸偶联得到;wherein the nucleoside modular unit is obtained by coupling two or more deoxynucleotides; 优选地,所述原料中还包括脱氧核苷酸单体。Preferably, the raw material also includes deoxynucleotide monomers. 2.根据权利要求1所述DNA的合成方法,其特征在于,进行偶联的核苷模块单元中的碱基为不同的碱基或相同的碱基。2 . The method for synthesizing DNA according to claim 1 , wherein the bases in the coupled nucleoside modular units are different bases or the same base. 3 . 3.根据权利要求1所述DNA的合成方法,其特征在于,所述核苷模块单元为二聚体模块单元、三聚体模块单元以及四聚体模块单元中的至少一种。3 . The method for synthesizing DNA according to claim 1 , wherein the nucleoside module unit is at least one of a dimer module unit, a trimer module unit and a tetramer module unit. 4 . 4.根据权利要求3所述DNA的合成方法,其特征在于,所述核苷模块单元为二聚体模块单元。4. The method for synthesizing DNA according to claim 3, wherein the nucleoside modular unit is a dimer modular unit. 5.根据权利要求1-4任一项所述DNA的合成方法,其特征在于,所述固相合成在DNA合成仪上进行。5. The method for synthesizing DNA according to any one of claims 1-4, wherein the solid-phase synthesis is performed on a DNA synthesizer. 6.根据权利要求1-4任一项所述DNA的合成方法,其特征在于,所述核苷模块单元的合成方法包括:6. The method for synthesizing DNA according to any one of claims 1-4, wherein the method for synthesizing the nucleoside modular unit comprises: (1)将保护基团保护的脱氧核苷与乙酰丙酸反应,碱性环境和催化条件下,获得活性基团被保护的脱氧核苷;(1) reacting the deoxynucleoside protected by the protective group with levulinic acid, under alkaline environment and catalytic conditions, to obtain the deoxynucleoside protected by the active group; (2)脱去其5’-羟基的保护基团,与亚磷酰胺核苷催化偶联,氧化;(2) Remove the protective group of its 5'-hydroxyl group, catalyze coupling with phosphoramidite nucleoside, and oxidize; 优选地,所述亚磷酰胺核苷所含的磷酯基选自甲基、乙基、丙基、异丙基的其中一种;Preferably, the phosphorus ester group contained in the phosphoramidite nucleoside is selected from one of methyl, ethyl, propyl, and isopropyl; (3)脱去其3’-羟基的保护基团,连接亚磷酰胺;(3) remove the protecting group of its 3'-hydroxyl, connect phosphoramidite; (4)当所述核苷模块单元中的碱基为两个以上时,重复上述步骤(2)-(3)以得到所述核苷模块单元;(4) when there are two or more bases in the nucleoside modular unit, repeat the above steps (2)-(3) to obtain the nucleoside modular unit; 优选地,所述保护基团选自三苯甲基基团、单甲氧基三苯甲基基团、二甲氧基三苯甲基基团中的其中一种。Preferably, the protecting group is selected from one of a trityl group, a monomethoxytrityl group, and a dimethoxytrityl group. 7.根据权利要求6所述DNA的合成方法,其特征在于,催化偶联的催化剂为1H-四唑、5-苄硫基四唑、4,5-二氰基咪唑中的其中一种。7 . The method for synthesizing DNA according to claim 6 , wherein the catalyst for catalytic coupling is one of 1H-tetrazole, 5-benzylthiotetrazole, and 4,5-dicyanoimidazole. 8 . 8.根据权利要求6所述的DNA的合成方法,其特征在于,催化偶联的催化剂为4,5-二氰基咪唑。8 . The method for synthesizing DNA according to claim 6 , wherein the catalyst for catalytic coupling is 4,5-dicyanoimidazole. 9 . 9.根据权利要求6所述DNA的合成方法,其特征在于,与质子酸反应以脱去其5’-羟基的保护基团;9. the synthetic method of DNA according to claim 6, is characterized in that, with protonic acid reaction to remove the protecting group of its 5'-hydroxyl; 优选地,所述质子酸选自三氯乙酸、二氯乙酸中的其中一种。Preferably, the protic acid is selected from one of trichloroacetic acid and dichloroacetic acid. 10.根据权利要求6所述DNA的合成方法,其特征在于,水合肼催化以脱去其3’-羟基的保护基团。10. The method for synthesizing DNA according to claim 6, wherein hydrazine hydrate catalyzes the removal of the protective group of its 3'-hydroxyl group.
CN201910222602.4A 2019-03-22 2019-03-22 A Modular DNA Synthesis Method Pending CN111718387A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910222602.4A CN111718387A (en) 2019-03-22 2019-03-22 A Modular DNA Synthesis Method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910222602.4A CN111718387A (en) 2019-03-22 2019-03-22 A Modular DNA Synthesis Method

Publications (1)

Publication Number Publication Date
CN111718387A true CN111718387A (en) 2020-09-29

Family

ID=72562801

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910222602.4A Pending CN111718387A (en) 2019-03-22 2019-03-22 A Modular DNA Synthesis Method

Country Status (1)

Country Link
CN (1) CN111718387A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114957364A (en) * 2022-05-31 2022-08-30 湖南大学 Iodoglycoside base, preparation method thereof and constructed amphiphilic nucleic acid
CN117362370A (en) * 2023-12-07 2024-01-09 北京百力格生物科技有限公司 Nucleoside phosphoramidite monomer and preparation method and application thereof
WO2024130904A1 (en) * 2022-12-22 2024-06-27 百力格生物科技(上海)股份有限公司 Method for synthesizing unique molecular identifier and molecular identifier connector thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101107262A (en) * 2005-01-28 2008-01-16 集润德斯股份公司 Purification of oligonucleotides
US20110137021A1 (en) * 2009-04-23 2011-06-09 A.M. Chemicals, Inc. Sulfur transfer reagents for oligonucleotide synthesis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101107262A (en) * 2005-01-28 2008-01-16 集润德斯股份公司 Purification of oligonucleotides
US20110137021A1 (en) * 2009-04-23 2011-06-09 A.M. Chemicals, Inc. Sulfur transfer reagents for oligonucleotide synthesis

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ACHIM H. KROTZ ET AL.: "PHOSPHOROTHIOATE OLIGONUCLEOTIDES:LARGELY REDUCED (N-1)-MER AND PHOSPHODIESTER CONTENT THROUGH THE USE OF DIMERIC PHOSPHORAMIDITE SYNTHONS", 《BIOORGANIC & MEDICINAL CHEMISTRY LETTERS》 *
G.KUMAR ET AL.: "Improvements in Oligodeoxyribonucleotide Synthesis : Methyl N,N-Dialkylphosphoramidite Dimer Units for Solid Support Phosphite Methodology", 《J. ORG. CHEM.》 *
龙敏南 等: "《基因工程(第二版)》", 30 September 2010 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114957364A (en) * 2022-05-31 2022-08-30 湖南大学 Iodoglycoside base, preparation method thereof and constructed amphiphilic nucleic acid
CN114957364B (en) * 2022-05-31 2024-01-23 湖南大学 Iodine base, preparation method thereof and constructed amphiphilic nucleic acid
WO2024130904A1 (en) * 2022-12-22 2024-06-27 百力格生物科技(上海)股份有限公司 Method for synthesizing unique molecular identifier and molecular identifier connector thereof
CN117362370A (en) * 2023-12-07 2024-01-09 北京百力格生物科技有限公司 Nucleoside phosphoramidite monomer and preparation method and application thereof
CN117362370B (en) * 2023-12-07 2024-03-05 北京百力格生物科技有限公司 Nucleoside phosphoramidite monomer and preparation method and application thereof

Similar Documents

Publication Publication Date Title
AU669103B2 (en) Improved process for the synthesis of oligomers
Cosstick et al. Synthesis of d (GC) and d (CG) octamers containing alternating phosphorothioate linkages: effect of the phosphorothioate group on the BZ transition
EP0815114B1 (en) Nucleic acid synthesis using photoremovable protecting groups
EP0543906B1 (en) Hydroxyl-protecting groups orthogonally removable by reduction and their use in the chemical synthesis of oligonucleotides
US20090005550A1 (en) Polynucleotide containing a phosphate mimetic
CN111704644B (en) Ammonolysis solution and ammonolysis method
CZ262998A3 (en) Synthesis process of oligonucleotide n3 - p5 phosphoramidates on solid phase
CN111718387A (en) A Modular DNA Synthesis Method
EP0289619B1 (en) Process for synthesizing oligonucleotides and compounds for forming high-molecular protective group
JP2010248084A (en) Method of synthesizing oligonucleotide using novel cleaning solvent
JPH0692435B2 (en) Phosphoramidite reagent for chemical synthesis of modified DNA
US4672110A (en) Method of deprotecting polynucleotide trimethylethyl phosphotriesters
EP0040099A1 (en) Polynucleotide synthesis
JPH08507752A (en) Synthesis of dimer block and oligonucleotide ligation method using dimer block
CA3141195C (en) Process for the preparation of oligonucleotides using modified oxidation protocol.
EA038579B1 (en) IMPROVED METHOD OF OBTAINING IMELSTAT
WO2005082923A1 (en) Novel method of synthesizing nucleic acid without protecting nucleotide bases
CN115010770B (en) Method for synthesizing RNA nucleic acid using mixed deprotection agent
Sekine et al. Synthesis of oligodeoxyribonucleotides involving a rapid procedure for removal of base-protecting groups by use of the 4, 4', 4"-tris (benzoyloxy) trityl (TBTr) group.
CN117756872A (en) Method for preparing N-acetylgalactosamine oligonucleotide conjugate based on click chemistry technology
CN117756871A (en) Method for preparing N-acetylgalactosamine oligonucleotide conjugate based on click chemistry technology
CA3181364A1 (en) Process for the preparation of oligonucleotides using modified oxidation protocol
JP2010539215A (en) Polymer phase synthesis method
JPS6379895A (en) Synthesis of polynucleotide
JPH0613548B2 (en) Solid-Phase Synthesis of Oligonucleotides Using Nucleoside Phosphorothioittes

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20200929